These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16889549)

  • 1. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.
    Saland JM; Emre SH; Shneider BL; Benchimol C; Ames S; Bromberg JS; Remuzzi G; Strain L; Goodship TH
    Am J Transplant; 2006 Aug; 6(8):1948-52. PubMed ID: 16889549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.
    Saland JM; Shneider BL; Bromberg JS; Shi PA; Ward SC; Magid MS; Benchimol C; Seikaly MG; Emre SH; Bresin E; Remuzzi G
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):201-6. PubMed ID: 19005013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
    Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
    Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H.
    Haller W; Milford DV; Goodship TH; Sharif K; Mirza DF; McKiernan PJ
    Am J Transplant; 2010 Sep; 10(9):2142-7. PubMed ID: 20738267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report.
    Neidich AB; Neidich EM; Lee A; Nicoletta J; Rohrer RJ; Milner LS; Cooper JT
    Prog Transplant; 2013 Sep; 23(3):213-6. PubMed ID: 23996939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir.
    Olie KH; Goodship TH; Verlaak R; Florquin S; Groothoff JW; Strain L; Weening JJ; Davin JC
    Am J Kidney Dis; 2005 Jan; 45(1):e12-5. PubMed ID: 15696434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.
    Jalanko H; Peltonen S; Koskinen A; Puntila J; Isoniemi H; Holmberg C; Pinomäki A; Armstrong E; Koivusalo A; Tukiainen E; Mäkisalo H; Saland J; Remuzzi G; de Cordoba S; Lassila R; Meri S; Jokiranta TS
    Am J Transplant; 2008 Jan; 8(1):216-21. PubMed ID: 17973958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.
    Remuzzi G; Ruggenenti P; Colledan M; Gridelli B; Bertani A; Bettinaglio P; Bucchioni S; Sonzogni A; Bonanomi E; Sonzogni V; Platt JL; Perico N; Noris M
    Am J Transplant; 2005 May; 5(5):1146-50. PubMed ID: 15816899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hemolytic uremic syndrome associated with complement factor H deficiency.
    Landau D; Shalev H; Levy-Finer G; Polonsky A; Segev Y; Katchko L
    J Pediatr; 2001 Mar; 138(3):412-7. PubMed ID: 11241053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy after kidney transplantation.
    Noris M; Remuzzi G
    Am J Transplant; 2010 Jul; 10(7):1517-23. PubMed ID: 20642678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
    Weitz M; Amon O; Bassler D; Koenigsrainer A; Nadalin S
    Pediatr Nephrol; 2011 Aug; 26(8):1325-9. PubMed ID: 21556717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
    Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
    Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M; Valoti E; Piras R; Bresin E; Galbusera M; Tripodo C; Thaiss F; Remuzzi G; Noris M
    Am J Transplant; 2013 Aug; 13(8):2201-6. PubMed ID: 23731345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.